PC-3 (人前列腺癌细胞) (STR鉴定正确)

一键复制产品信息

参考文献

• Retinoblastoma-associated protein is important for TRIM24-mediated activation of the mTOR signaling pathway through DUSP2 action in prostate cancer(2024/03/21)

  作者：Da Ren, Wei Li, Ruijiang Zeng

  期刊：CELL DEATH AND DIFFERENTIATION

  DOI：10.1038/s41418-024-01282-w

  影响因子 ：12.400

  引用产品：CL-0185

• Targeted Ultrasound Nanobubbles Therapy for Prostate Cancer via Immuno-Sonodynamic Effect(2024/03/18)

  作者：Xin Huang, Yueying Chen, Fanglu Zhong

  期刊：International Journal of Nanomedicine

  DOI：10.2147/IJN.S451179

  影响因子 ：8.000

  引用产品：CL-0185

• PEG-coated and Gd-loaded fluorescent silica nanoparticles for targeted prostate cancer magnetic resonance imaging and fluorescence imaging(2023/01/02)

  作者：Wei Jiang, Huiying Fang, Fengqiu Liu

  期刊：International Journal of Nanomedicine

  DOI：10.2147/IJN.S207098

  影响因子 ：8.000

  引用产品：CL-0185

• Diterpenoid honatisine overcomes temozolomide resistance in glioblastoma by inducing mitonuclear protein imbalance through disruption of TFAM-mediated mtDNA transcription(2023/12/29)

  作者：Zongyang Li, Ke Sai, Guoxu Ma

  期刊：PHYTOMEDICINE

  DOI：10.1016/j.phymed.2023.155328

  影响因子 ：7.900

  引用产品：CL-0185

• ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003(2023/12/04)

  作者：Yupeng Wu, Wencai Zheng, Qi Huang

  期刊：Journal of Translational Medicine

  DOI：10.1186/s12967-023-04760-w

  影响因子 ：7.400

  引用产品：CL-0185

• Design, Synthesis, and Biological Evaluation of Proteolysis-Targeting Chimeras as Highly Selective and Efficient Degraders of Extracellular Signal-Regulated Kinase 5(2023/09/26)

  作者：Pengming Pan, Tongtong Geng, Zhongtang Li

  期刊：JOURNAL OF MEDICINAL CHEMISTRY

  DOI：10.1021/acs.jmedchem.3c00864

  影响因子 ：7.300

  引用产品：CL-0014 CL-0096 CL-0103 CL-0185 CL-0233 CL-0298

• Bimetallic Nanoplatform Dedicated to Sonodynamic-Calcium Overload Synergistic Therapy via Self-supplied Hydrogen Peroxide and Relieved Hypoxia(2023/12/12)

  作者：Wenqian Xu, Yisheng Zhao, Chao Zhang

  期刊：Biomaterials Science

  DOI：10.1039/D3BM01430D

  影响因子 ：6.600

  引用产品：CL-0185

• Metabolic characterization of sphere-derived prostate cancer stem cells reveals aberrant urea cycle in stemness maintenance(2024/04/22)

  作者：Yuanyuan Luo, Jiachuan Yu, Zhikun Lin

  期刊：INTERNATIONAL JOURNAL OF CANCER

  DOI：10.1002/ijc.34967

  影响因子 ：6.400

  引用产品：CL-0185

• Risk subtyping and prognostic assessment of prostate cancer based on consensus genes(2022/03/15)

  作者：Jialin Meng, Yu Guan, Bijun Wang

  期刊：Communications Biology

  DOI：10.1038/s42003-022-03164-8

  影响因子 ：5.900

  引用产品：CL-0185

• β-hydroxybutyrate inhibits malignant phenotypes of prostate cancer cells through β-hydroxybutyrylation of indoleacetamide-N-methyltransferase(2024/03/30)

  作者：Yifan Zhang, Yunlong Li

  期刊：Cancer Cell International

  DOI：10.1186/s12935-024-03277-6

  影响因子 ：5.800

  引用产品：CL-0185

• AID-induced CXCL12 upregulation enhances castration-resistant prostate cancer cell metastasis by stabilizing β-catenin expression(2023/11/23)

  作者：Qi Li, Jinfeng Fan, Zhiyan Zhou

  期刊：iScience

  DOI：10.1016/j.isci.2023.108523

  影响因子 ：5.800

  引用产品：CL-0185

• Identification of pyroptosis-related lncRNA signature and AC005253.1 as a pyroptosis-related oncogene in prostate cancer.(2022/09/29)

  作者：JiangFan Yu, Rui Tang, JinYu Li

  期刊：Frontiers in Oncology

  DOI：10.3389/fonc.2022.991165

  影响因子 ：5.738

  引用产品：CL-0185

• A Liquid–Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer Patients(2023/03/14)

  作者：Qi You, Jiayin Chen, Xiaohui Wu

  期刊：INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

  DOI：10.3390/ijms24065515

  影响因子 ：5.600

  引用产品：CL-0004 CL-0075 CL-0185 CM-0075 CM-0185

• Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis.(2022/09/21)

  作者：Longfei Yang, Yuwei Zhang, Yang Wang

  期刊：Frontiers in Pharmacology

  DOI：10.3389/fphar.2022.938134

  影响因子 ：5.600

  引用产品：CL-0002 CL-0010 CL-0052 CL-0075 CL-0109 CL-0185 CL-0222 CL-0227 CM-H019 PM150110 PM150210 PM150910

• A Moexitecan Magnetic Liposomal Strategy for Ferroptosis-Enhanced Chemotherapy(2023/07/24)

  作者：Weiling Miao, Yang Liu, Jian Tang

  期刊：Pharmaceutics

  DOI：10.3390/pharmaceutics15072012

  影响因子 ：5.400

  引用产品：CL-0103 CL-0118 CL-0185 PM150410 PM150710 PM150910

• LOC100996425 acts as a promoter in prostate cancer by mediating hepatocyte nuclear factor 4A and the AMPK/mTOR pathway(2021/08/19)

  作者：Xiuyan Wang, Bin Song, Mingcui Zang

  期刊：Journal Of Cellular And Molecular Medicine

  DOI：10.1111/jcmm.16657

  影响因子 ：5.300

  引用产品：CL-0004 CL-0075 CL-0143 CL-0185

• MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways(2021/11/10)

  作者：Sihai Zhou, Zhihong Dai, Liang Wang

  期刊：Journal Of Cellular And Molecular Medicine

  DOI：10.1111/jcmm.17037

  影响因子 ：5.295

  引用产品：CL-0004 CL-0075 CL-0143 CL-0185

• PCMT1 regulates the migration, invasion, and apoptosis of prostate cancer through modulating the PI3K/AKT/GSK-3β pathway.(2023/10/27)

  作者：Jiacheng Zhong, Chao Yuan, Lin Liu

  期刊：Aging-US

  DOI：10.18632/aging.205152

  影响因子 ：5.200

  引用产品：CL-0185

• Synthesis and preclinical evaluation of a novel probe [18F]AlF-NOTA-IPB-GPC3P for PET imaging of GPC3 positive tumor(2024/04/14)

  作者：Chunwei Mo, Penghui Sun, Haoran Liang

  期刊：BIOORGANIC CHEMISTRY

  DOI：10.1016/j.bioorg.2024.107352

  影响因子 ：5.100

  引用产品：CL-0185

• 177Lu-Labeled Bivalent Ligands of Prostate-Specific Membrane Antigen for Endoradiotherapy of Prostate Cancer(2023/12/28)

  作者：Ruoxue Dai, Zhikai Cai, Rui Hu

  期刊：MOLECULAR PHARMACEUTICS

  DOI：10.1021/acs.molpharmaceut.3c00987

  影响因子 ：4.900

  引用产品：CL-0185

• Effect of transmembrane protein 100 on prostate cancer progression by regulating SCNN1D through the FAK/PI3K/AKT pathway(2022/11/11)

  作者：Zehua Ye, Yuqi Xia, Lei Li

  期刊：Translational Oncology

  DOI：10.1016/j.tranon.2022.101578

  影响因子 ：4.803

  引用产品：CL-0185

• YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation(2024/03/09)

  作者：Xuefeng Zhao, Suli Lv, Neng Li

  期刊：JOURNAL OF BIOLOGICAL CHEMISTRY

  DOI：10.1016/j.jbc.2024.107152

  影响因子 ：4.800

  引用产品：CL-0185

• Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer(2023/08/16)

  作者：Hongzhuang Wen, Changbao Qu, Zhu Wang

  期刊：FASEB JOURNAL

  DOI：10.1096/fj.202300980R

  影响因子 ：4.800

  引用产品：CL-0004 CL-0143 CL-0185

• Comprehensiveness cuproptosis related genes study for prognosis and medication sensitiveness across cancers, and validation in prostate cancer(2024/04/26)

  作者：Longfei Yang, Yifan Tang, Yuwei Zhang

  期刊：Scientific Reports

  DOI：10.1038/s41598-024-57303-8

  影响因子 ：4.600

  引用产品：CL-0185

• A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance(2023/04/08)

  作者：Longfei Yang, Yuwei Zhang, Yifan Tang

  期刊：Scientific Reports

  DOI：10.1038/s41598-023-27975-9

  影响因子 ：4.600

  引用产品：CL-0002 CL-0010 CL-0052 CL-0075 CL-0109 CL-0185 CL-0222 CL-0227 CM-H019 PM150110 PM150210 PM150910

• Epigenetic activation of METTL14 promotes docetaxel resistance in prostate cancer by promoting pri-microRNA-129 maturation(2024/03/28)

  作者：Cheng Wu, Chunqing Miao, Songlin Zhou

  期刊：ENVIRONMENTAL TOXICOLOGY

  DOI：10.1002/tox.24187

  影响因子 ：4.500

  引用产品：CL-0185

• A ratiometric near-infrared fluorescence strategy based on spiropyran in situ switching for tracking dynamic changes of live-cell lysosomal pH(2019/03/27)

  作者：Jin Li, Xiaokang Li, Jianbo Jia

  期刊：Dyes And Pigments

  DOI：10.1016/j.dyepig.2019.03.060

  影响因子 ：4.500

  引用产品：CL-0103 CL-0149 CL-0185 CL-0519

• YAP1 inhibits RSL3-induced castration-resistant prostate cancer cell ferroptosis by driving glutamine uptake and metabolism to GSH(2023/09/29)

  作者：Xian Fu, Hongshen Wu, Changjiu Li

  期刊：MOLECULAR AND CELLULAR BIOCHEMISTRY

  DOI：10.1007/s11010-023-04847-4

  影响因子 ：4.300

  引用产品：164210 CL-0075 CL-0185 PM150410 PM150910

• Epigenetic-related Gene-based Prognostic Model Construction and Validation in Prostate Adenocarcinoma(2024/05/08)

  作者：Youyou Li, Chao Li, Longxiang Wu

  期刊：Heliyon

  DOI：10.1016/j.heliyon.2024.e30941

  影响因子 ：4.000

  引用产品：CL-0185

• Identification of evodiamine as a suppressor of prostate cancer progression by reducing AR transcriptional activity via targeting Src(2021/10/28)

  作者：Pei Cheng, Xiaofan Zhang, Xiaofu Wang

  期刊：Endocrine

  DOI：10.1007/s12020-021-02907-7

  影响因子 ：3.925

  引用产品：CL-0075 CL-0185

• Analyzing roles of small nucleolar RNA host gene 25 from clinical, molecular target and tumor formation in prostate cancer(2023/06/10)

  作者：Zelin Liu, Shuai Ke, Qinghua Wang

  期刊：EXPERIMENTAL CELL RESEARCH

  DOI：10.1016/j.yexcr.2023.113686

  影响因子 ：3.700

  引用产品：CL-0075 CL-0143 CL-0185 CL-0467

• A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer(2023/02/24)

  作者：Lei Ren, Xu Yang, Weifeng Wang

  期刊：Frontiers in Genetics

  DOI：10.3389/fgene.2023.1096783

  影响因子 ：3.700

  引用产品：CL-0075 CL-0143 CL-0185

• NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway(2020/3/28)

  作者：Shengjun Luo, Lan Shao, Zhixiong Chen

  期刊：Experimental Cell Research

  DOI：10.1016/j.yexcr.2020.111981

  影响因子 ：3.700

  引用产品：CL-0185

• Crafting a Personalized Prognostic Model for Malignant Prostate Cancer Patients Using Risk Gene Signatures Discovered through TCGA-PRAD Mining, Machine Learning, and Single-Cell RNA-Sequencing(2023/06/07)

  作者：Feng Lyu, Xianshu Gao, Mingwei Ma

  期刊：Diagnostics

  DOI：10.3390/diagnostics13121997

  影响因子 ：3.600

  引用产品：CL-0004 CL-0075 CL-0185

• Silencing of MALAT1 inhibits migration and invasion by sponging miR‑1‑3p in prostate cancer cells(2019/08/22)

  作者：Xiaofan Dai, Zuowen Liang, Lingyun Liu

  期刊：Molecular Medicine Reports

  DOI：10.3892/mmr.2019.10602

  影响因子 ：3.400

  引用产品：CL-0005 CL-0075 CL-0185 CM-0075 CM-0185

• Sennoside A induces autophagic death of prostate cancer via inactivation of PI3K/AKT/mTOR axis(2023/09/23)

  作者：Shaoyi Qiao, Wuhe Zhang, Yao Jiang

  期刊：JOURNAL OF MOLECULAR HISTOLOGY

  DOI：10.1007/s10735-023-10156-3

  影响因子 ：3.200

  引用产品：164210-50 CL-0185 CL-0233 PB180120 PM150410 PM150910

• PEI, a new transfection method, augments the inhibitory effect of RBM5 on prostate cancer(2024/02/21)

  作者：Xijia Zhou, Yingshu Cao, Ranwei Li

  期刊：BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

  DOI：10.1016/j.bbrc.2024.149703

  影响因子 ：3.100

  引用产品：CL-0185

• Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration‑resistant prostate cancer(2020/11/19)

  作者：Mingqiu Hu, Jing Ning, Likai Mao

  期刊：Oncology Letters

  DOI：10.3892/ol.2020.12324

  影响因子 ：2.900

  引用产品：CL-0185

• Silencing of lncRNA MALAT1 inhibits cell cycle progression via androgen receptor signaling in prostate cancer cells(2019/1/7)

  作者：Xiaofan Dai, Lingyun Liu, Zuowen Liang

  期刊：Pathology Research And Practice

  DOI：10.1016/j.prp.2019.01.011

  影响因子 ：2.800

  引用产品：CL-0075 CL-0185 PM150410 PM150910

• IU1 and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer(2023/08/07)

  作者：Yifan Zhang, Yuanpeng Liao, Mayao Luo

  期刊：PROSTATE

  DOI：10.1002/pros.24607

  影响因子 ：2.800

  引用产品：CL-0004 CL-0143 CL-0185

• GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer(2022/10/25)

  作者：Ming Yang, Xudong Zhu, Yang Shen

  期刊：PeerJ

  DOI：10.7717/peerj.14263

  影响因子 ：2.700

  引用产品：CL-0004 CL-0075 CL-0143 CL-0185

• Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer(2023/04/12)

  作者：Qingfu Zhang, Peng Zhang, Zhongting Zhao

  期刊：PeerJ

  DOI：10.7717/peerj.15013

  影响因子 ：2.700

  引用产品：CL-0004 CL-0075 CL-0143 CL-0185

• Hsa_circ_0074032 promotes prostate cancer progression through elevating homeobox A1 expression by serving as a microRNA-198 decoy(2021/11/19)

  作者：Chuanshun Feng, Qinjun Wang, Ling Deng

  期刊：Andrologia

  DOI：10.1111/and.14312

  影响因子 ：2.400

  引用产品：164210 164210-50 CL-0075 CL-0143 CL-0185 PB180120 PM150110 PM150410 PM150910

• TRPM2-L Participates in the Interleukin-6 Pathway to Enhance Tumor Growth in Prostate Cancer by Hypoxia-Inducible Factor-1α(2023/11/10)

  作者：Kai Cheng, Qingmei Jia, Christopher Batbatan

  期刊：JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

  DOI：10.1089/jir.2023.0088

  影响因子 ：2.300

  引用产品：CL-0185

• Inhibitory function of CDK12i combined with WEE1i on castration-resistant prostate cancer cells in vitro and in vivo(2023/08/08)

  作者：Zheng Qin, Dongze Liu, Yueyao Zhang

  期刊：Oncologie

  DOI：10.1515/oncologie-2023-0233

  影响因子 ：0.900

  引用产品：CL-0075 CL-0185

点击展开收起列表